RxDoctor Payments Data

Kami Chandler, NP

Nurse Practitioner · Nashville, TNNPI 1316412158

Payments from drug & device makers

$1,987in general payments, 2019–2025

Across 117 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Medtronic$174
  • Novo Nordisk$80
  • E.r. Squibb & Sons, L.L.C.$58
  • Boehringer Ingelheim$49
  • Johnson & Johnson$44
  • plus $124 from 6 others

What the payments were for

  • Food & beverage$1,97099%
  • Education$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,987 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,739
Medicare patients
400
Services billed
631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$41,811
Repatha SureclickEvolocumab36$31,194
BrilintaTicagrelor53$26,279
XareltoRivaroxaban22$18,577
EntrestoSacubitril/Valsartan18$12,048
ClopidogrelClopidogrel Bisulfate284$2,257
Atorvastatin Calcium134$1,604
Prasugrel Hcl21$1,349
Metoprolol Succinate77$1,124
Losartan Potassium75$879
Rosuvastatin Calcium57$688
Nitroglycerin37$261
Diltiazem 24hr Er (Cd)Diltiazem Hcl16$243
Spironolactone33$155
Potassium Chloride16$153

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$44$18,57722 claims
NovartisEntresto$20$12,04818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →